Putting the patient at the heart of decentralized clinical trials: an interview with Henrik Vincentz, James Lind Care

The COVID-19 pandemic has been a catalyst for many advances across the spectrum of clinical research and healthcare. One of these is the wider adoption of decentralized clinical trials (DCTs), fueled by digital health technologies, which have been shown to have many benefits, such as improved patient and physician experiences and increased diversity and equity of trial participants. Here we speak with Henrik Vincentz, Director and Founder of James Lind Care about patient engagement and the role of the patient voice in DCTs. Please could you introduce yourself, your organization(s) and give a brief overview of your career to date?...